Related Experiment Video
Updated: Apr 11, 2026
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
One-step scalable preparation method for non-cationic liposomes with high siRNA content
Masaharu Somiya1, Kotomi Yamaguchi2, Qiushi Liu3
1Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan; Japan Society for the Promotion of Science, Tokyo 102-0083, Japan; The Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.
Researchers developed a novel method for encapsulating short interfering RNA (siRNA) into non-cationic liposomes (LPs), overcoming previous toxicity issues. This advancement enables safer and more effective siRNA delivery for potential therapeutic applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- Cationic liposomes (LPs) are effective for short interfering RNA (siRNA) delivery due to electrostatic binding.
- Clinical applications of cationic LPs are hindered by cytotoxicity and non-specific adsorption.
- Encapsulating siRNA within non-cationic LPs presents a safer alternative.
Purpose of the Study:
- To develop a method for efficient siRNA encapsulation in non-cationic LPs.
- To assess the characteristics and safety of these novel siRNA-loaded LPs.
- To evaluate the potential of these LPs for targeted gene silencing.
Main Methods:
- A novel method involving the instillation of neutral phospholipids in ethanol into aqueous solutions of siRNA and CaCl2.
- Characterization of liposome size, charge, encapsulation efficiency, and siRNA content.
- In vitro cytotoxicity assays and gene silencing studies using targeted LPs.
Main Results:
- High siRNA encapsulation efficiency (~80%) and siRNA weight ratio (~10 wt%) achieved in monodispersed, negatively charged LPs (~200 nm).
- Encapsulation remained high with phospholipids having high-phase transition temperatures or cholesterol.
- Non-cationic LPs showed no in vitro cytotoxicity and enabled gene silencing when conjugated with targeting ligands.
Conclusions:
- A scalable and efficient method for producing non-cationic siRNA-loaded LPs was established.
- These LPs offer a promising, non-toxic platform for systemic siRNA delivery.
- The developed LPs demonstrate potential for targeted gene therapy applications.
